blozf stock — BLOZF (Cannabix Technologies Inc.)

BLOZF (Cannabix Technologies Inc.) — Stock

blozf stock is the OTC‑traded ticker representing Cannabix Technologies Inc., a Canadian developer of breathalyzer technologies designed to detect recent cannabis (THC) use and breath alcohol levels. This article explains what the blozf stock listing represents, summarizes the company’s history and products, outlines trading characteristics and available financial data, highlights regulatory and commercial milestones, and lists the main risks investors and observers should consider. Readers will find quick reference information, sources to verify live market data, and guidance on how to follow updates — plus a Bitget‑focused call to action at the end for those interested in trading or wallet options.

Note: This article is informational and neutral in tone. It is not investment advice. Live market figures for blozf stock change frequently; always consult real‑time market pages and official filings for current numbers.

Infobox (summary data)

As of 2024-06-01, according to market pages such as MarketWatch and OTC Markets, real‑time pricing and market cap for blozf stock are actively updated; readers should check those providers for current numbers.

Overview

BLOZF represents the publicly traded equity of Cannabix Technologies Inc., a Canadian company that develops non‑invasive breath testing technology aimed at detecting recent cannabis (THC) consumption and providing breath alcohol measurement. The company pursues products intended for law enforcement, workplace testing, transportation safety, and other institutional use cases where rapid screening for recent impairment is required.

For readers unfamiliar with the space: blozf stock is an OTC‑listed security. OTC securities often have lower liquidity and fewer reporting obligations than exchange‑listed equities. The phrase "blozf stock" throughout this article refers specifically to the market ticker and the publicly traded shares of Cannabix Technologies Inc.

Company background

Cannabix Technologies Inc. traces its origins to 2011, when the firm was formed to research and develop breath testing technology for recent cannabis use. Headquartered in Burnaby, British Columbia, the company has focused on creating a rapid, non‑invasive breathalyzer intended to identify recent THC exposure rather than longer‑term metabolites detected in urine.

The company has undergone corporate changes and has, at times, operated under legacy shell or corporate names as it raised capital and transitioned into product development. Historically, small, publicly traded Canadian companies sometimes use reverse takeovers or name changes during restructuring; consult the company’s continuous disclosure records on SEDAR/SEDAR+ for the official corporate history and any prior names.

Management and board composition have shifted over time; the company typically publishes corporate filings and press releases listing current officers and directors. For the latest management roster and biographies, review the company’s investor disclosures and official announcements.

Products and technology

Cannabix’s product portfolio centers on breath analysis technologies with two core thrusts:

• THC breath analyzers: devices designed to detect recent inhalation or exposure to cannabis (THC) via breath samples. These devices aim to measure recent impairment windows (minutes to hours) rather than metabolites that can persist in blood or urine for days.

• Breath alcohol devices (BreathLogix and related systems): breathalyzers for alcohol testing, typically designed to meet law enforcement or workplace screening needs. These systems often include breath collection units, sampling interfaces, and digital readouts or connectivity for data capture.

Target markets for Cannabix’s technologies include law enforcement agencies seeking roadside or evidentiary tools, employers requiring impairment screening solutions in safety‑sensitive industries, government transportation authorities, and contracted laboratories or distribution partners. The company has emphasized portability, rapid results, and non‑invasive sampling as distinguishing features.

Technical and regulatory validation is central to commercial adoption. Breath detection for THC is a difficult technical problem due to low concentrations and transient presence of THC in breath; sensitivity, specificity, device calibration, and field validation are critical.

Corporate history and milestones

Below is a concise timeline of types of milestones investors and observers typically track for a company like Cannabix. Specific dates and details should be verified against the company’s press releases and filing history.

• 2011: Company founding and initial R&D into breath testing for THC.
• Product development phases: prototype announcements for a THC breathalyzer and iterations on collection hardware and software platforms.
• Distribution and partnership agreements: Cannabix has historically announced distribution or reseller agreements aimed at law enforcement or corporate markets; the commercial impact of such agreements depends on contract scale and implementation timelines.
• Regulatory milestones: announcements of submitted testing protocols, field trials, or third‑party validations; formal regulatory approvals (where applicable) are key inflection points.
• Public listing and OTC trading: the issuance and trading of stock under the ticker BLOZF on an OTC venue, making the company accessible to public investors.

As with many small tech/medical OTC issuers, material developments are often communicated through company press releases posted to official distribution channels. As of 2024‑06‑01, company press releases and filings remain the primary source for exact dates and details.

Stock listing and trading information

Ticker and market

• Ticker: BLOZF
• Market: OTC (commonly quoted on OTC Pink/OTCPK tiers). Trading currency is typically U.S. dollars for OTC quotes.

blozf stock trades on the over‑the‑counter market rather than a major U.S. exchange. That classification affects disclosure, liquidity, and market‑making, and investors should confirm the current OTC tier and trading status via the OTC Markets website or equivalent market data providers.

Trading characteristics

• Liquidity: OTC Pink‑tier securities like blozf stock often experience low daily volume and wide bid‑ask spreads. Liquidity can vary widely day‑to‑day, and single large orders may materially move price.

• Volatility: Penny and OTC stocks can be highly volatile. For blozf stock, volatility is influenced by company announcements, small float size, and retail interest.

• Data latency and quotes: OTC pricing data can be delayed or segmented between different providers. Some platforms present last sale data only when trades occur; quoted bid/ask may not represent executable prices. Confirm live quotes on major market pages and through your broker.

• Trading hours: BLOZF trades during U.S. market hours on OTC venues; after‑hours liquidity is generally lower and continuous electronic quoting may be limited.

Historical price data

• 52‑week range, notable spikes/drawdowns, and average volume: These metrics are reported by market pages. For blozf stock, historical range and volatility should be examined over multiple windows (30/90/365 days) to assess behavior.

• Sources for charts: Use providers such as MarketWatch, Barchart, Nasdaq quote pages, and OTC Markets for historical data and interactive charts. Because OTC data may differ, cross‑check multiple vendors for consistency.

As of 2024-06-01, according to MarketWatch and OTC Markets, blozf stock’s historical price charts show periods of low liquidity and episodic volume spikes linked to company press releases. Readers should consult live market pages for up‑to‑the‑minute price history.

Financials and operating metrics

Publicly available financial data for small OTC issuers can be sparse, irregular, or dated. The most reliable sources are the company’s audited annual reports, interim filings, and audited financial statements filed on SEDAR/SEDAR+ or supplied to OTC disclosure platforms.

Key financial metrics to check for blozf stock include:

• Revenue (TTM): historical revenue may be limited if the company is still in product rollout or pre‑revenue stages. Verify reported revenue in the most recent quarterly/annual statements.

• Profitability (EPS, net income): many R&D‑heavy early-stage technology companies report operating losses and negative EPS. Expect irregular profitability until commercial revenues scale.

• Balance sheet highlights (cash, short‑term investments, debt): cash runway, recent financings, and convertible or debt obligations directly affect dilution and financing risk.

• Recent quarterly/annual results: look for year‑over‑year revenue trends, gross margin (if applicable), R&D spend, and operating expenses.

• Guidance: OTC issuers may not provide formal guidance. Use company statements for indications of expected commercialization timelines but treat these as non‑binding.

If detailed numbers are unavailable in the public domain, note the absence and rely on direct company filings for verification. Do not rely solely on third‑party aggregators for critical balance sheet figures.

Ownership, float and insider activity

• Shares outstanding and public float: These are reported in filings and on some market pages. For blozf stock, the free float can be small, which increases susceptibility to price volatility from relatively small trades.

• Major holders: Institutional ownership in many OTC penny stocks is often limited. Major holders may include insiders, founders, or early investors. Confirm major shareholdings through periodic disclosure filings.

• Insider transactions: Company officers and directors must disclose certain trades. Check the issuer’s regulatory filings and disclosure platforms for recent insider buys, sells, or grants.

• Filings: For Canadian issuers, SEDAR/SEDAR+ filings and OTC disclosure pages are primary sources for share counts and insider activity.

Analyst coverage and price targets

Analyst coverage for blozf stock is typically sparse. OTC and penny stocks often lack formal sell‑side research from major brokerages and therefore may have limited or no consensus price targets. Third‑party price estimates or projections found on investment blogs or small research shops should be treated cautiously and cross‑checked against primary filings.

When analyst estimates exist, note methodological caveats: limited coverage, thin trading history, and small revenue bases make forecasts highly uncertain. Investors should rely more heavily on company disclosures than on sparse analyst commentary for operational facts.

News, partnerships and commercial agreements

Cannabix has used press releases to announce product prototypes, distribution arrangements, field trials, and other commercial activities. Typical categories of news to monitor for blozf stock include:

• Distribution agreements or reseller partnerships that could enable access to law enforcement or workplace channels.
• Field trials or pilot deployments with police agencies, transportation authorities, or private employers.
• Third‑party validation studies or academic collaborations testing device accuracy and reliability.
• Manufacturing partnerships or supply chain announcements relevant to scaling production.

As of 2024-06-01, the company’s official press releases published via recognized distribution services (for example, GlobeNewswire or similar services) are the primary way Cannabix communicates new agreements. Always reference the dated press release for specifics on scope, geographic coverage, and commercial terms.

Regulatory and legal considerations

Regulatory approval and standards compliance are essential for breath testing devices to gain acceptance in law enforcement and occupational settings. Key regulatory and legal considerations for Cannabix and for any company producing THC breath analyzers include:

• Device validation and accuracy: Law enforcement agencies and courts require reliable scientific validation. Devices must demonstrate sensitivity and specificity for recent THC use to be useful in roadside or evidentiary contexts.

• Certification and standards: Breath alcohol devices often follow recognized standards (e.g., local law enforcement calibration standards). THC breath devices may be subject to additional scientific scrutiny and, in some jurisdictions, regulatory review.

• Privacy and data protection: Breath testing devices that log or transmit results must adhere to applicable privacy and data retention laws, especially when deployed by public agencies or employers.

• Legal admissibility: A breath test must meet legal thresholds to be admissible in courts. Device manufacturers must work with regulators, forensic labs, and law enforcement to ensure results are defensible.

• Product liability and recalls: If a device produces inaccurate results that lead to legal disputes, the company may face liability claims or reputational harm.

Any reported regulatory approvals, pilot results, or legal findings should be verified with the original release date and source. For example: As of 2024-05-15, the company published a press release reporting the start of a field validation program (source: Cannabix press release distributed via the company’s investor communication channels). Always check the date and primary source.

Risks and controversies

Investors and observers should consider the following risks commonly associated with small‑cap OTC technology/medical companies like the issuer behind blozf stock:

• Product commercialization risk: Technical challenges and the difficulty of reliably detecting THC in breath can delay or prevent commercial adoption.

• Regulatory risk: Lack of recognized standards or failure to obtain required validations can impede sales to law enforcement and institutional customers.

• Low liquidity and market risk: blozf stock, traded OTC, can have low daily volume and wide spreads, increasing the execution risk for buyers and sellers.

• Dilution risk: Small public companies frequently raise capital via equity issuances, which can dilute existing shareholders.

• Limited operating history: Historic financial losses, reliance on R&D funding, and an early commercial stage can make future cash flows uncertain.

• Reputational and legal risk: Any contested device results, product recalls, or lawsuits could materially harm adoption and revenue prospects.

These are general risk categories; consult the issuer’s publicly filed risk disclosures for a company‑specific list and details.

Market reception and investor interest

• Retail vs. institutional interest: OTC equities like blozf stock often draw retail investor attention, smaller private investors, and traders seeking speculative opportunities. Institutional coverage is typically limited.

• Trading patterns: blozf stock has historically shown episodic trading volume spikes around company press releases. Because float and liquidity are constrained, these spikes can produce pronounced price movements.

• Media coverage: Coverage on mainstream financial portals may be limited; niche financial websites and press platforms report on issuance and corporate announcements. Verify that any media report cites primary filings or press releases.

• Short interest and injections of retail interest: Short interest data may not be reliably reported for all OTC tickers. Where available, short data should be cross‑checked on multiple data platforms.

See also

• Cannabis impairment testing technologies
• Breathalyzer manufacturers and breath testing standards
• Investing in OTC markets and penny stocks
• Regulatory frameworks for roadside impairment testing

References and data sources

Primary sources to verify figures and announcements about blozf stock include:

• Company official press releases and investor communications (check the company’s investor relations materials)
• MarketWatch (BLOZF quote pages)
• OTC Markets and its issuer profile pages
• Nasdaq and other market data vendors that track OTC tickers
• Barchart and other charting providers for historical price data
• SEDAR/SEDAR+ for Canadian issuer filings
• Third‑party analytical sites and financial portals that aggregate OTC quotes

As of 2024-06-01, market pages such as MarketWatch and OTC Markets provide live quotes and reference data for blozf stock; check those sources for current trading metrics and historical charts.

External links

• Cannabix Technologies Inc. — official corporate website and investor relations (consult the company site for the latest contact information and filings)
• Market data pages such as MarketWatch, OTC Markets, and Barchart for live quotes and historical charts
• Company press release distribution pages where Cannabix posts formal announcements (refer to dated press releases for verification)

Notes on sourcing and scope

This article is structured using publicly available market pages and typical information flow for OTC issuers. Because blozf stock trades on an OTC venue and company developments occur intermittently, data such as market capitalization, share counts, and live quotes change frequently. Readers should verify numeric figures with live market pages and the company’s most recent filings. The narrative above synthesizes company focus, product categories, and typical OTC trading and regulatory issues relevant to BLOZF.

How to follow blozf stock and next steps

• Verify live pricing: consult MarketWatch, OTC Markets, Barchart, or your brokerage platform for the latest quote on blozf stock.

• Read company filings: for share counts, financial statements, and insider transactions, consult SEDAR/SEDAR+ and OTC disclosure documents.

• Monitor press releases: major product validation, distribution agreements, or regulatory approvals often trigger market activity in blozf stock.

• Account for OTC risks: low liquidity and potential dilution are common; treat OTC positions with appropriate sizing and risk limits.

If you plan to trade BLOZF, consider using a regulated platform with OTC access. Bitget offers access for traders who wish to explore a broad range of markets and provides a Bitget Wallet for secure custody of digital assets. For equities traded on OTC markets, use a broker that supports OTC execution and confirm the trading venue and order routing.

Further exploration and verification are recommended before taking any trading actions. For the most current market details for blozf stock, consult primary market pages and the issuer’s official disclosures.

Article last compiled on 2024-06-01. Market and company data are subject to change; readers should verify dates and figures against original sources and live market pages such as MarketWatch, OTC Markets, and the company’s filings on SEDAR/SEDAR+.